The University of Southampton
University of Southampton Institutional Repository

Update of the fracture risk prediction tool FRAX: A systematic review of potential cohorts and analysis plan

Update of the fracture risk prediction tool FRAX: A systematic review of potential cohorts and analysis plan
Update of the fracture risk prediction tool FRAX: A systematic review of potential cohorts and analysis plan

Summary: We describe the collection of cohorts together with the analysis plan for an update of the fracture risk prediction tool FRAX with respect to current and novel risk factors. The resource comprises 2,138,428 participants with a follow-up of approximately 20 million person-years and 116,117 documented incident major osteoporotic fractures. Introduction: The availability of the fracture risk assessment tool FRAX® has substantially enhanced the targeting of treatment to those at high risk of fracture with FRAX now incorporated into more than 100 clinical osteoporosis guidelines worldwide. The aim of this study is to determine whether the current algorithms can be further optimised with respect to current and novel risk factors. Methods: A computerised literature search was performed in PubMed from inception until May 17, 2019, to identify eligible cohorts for updating the FRAX coefficients. Additionally, we searched the abstracts of conference proceedings of the American Society for Bone and Mineral Research, European Calcified Tissue Society and World Congress of Osteoporosis. Prospective cohort studies with data on baseline clinical risk factors and incident fractures were eligible. Results: Of the 836 records retrieved, 53 were selected for full-text assessment after screening on title and abstract. Twelve cohorts were deemed eligible and of these, 4 novel cohorts were identified. These cohorts, together with 60 previously identified cohorts, will provide the resource for constructing an updated version of FRAX comprising 2,138,428 participants with a follow-up of approximately 20 million person-years and 116,117 documented incident major osteoporotic fractures. For each known and candidate risk factor, multivariate hazard functions for hip fracture, major osteoporotic fracture and death will be tested using extended Poisson regression. Sex- and/or ethnicity-specific differences in the weights of the risk factors will be investigated. After meta-analyses of the cohort-specific beta coefficients for each risk factor, models comprising 10-year probability of hip and major osteoporotic fracture, with or without femoral neck bone mineral density, will be computed. Conclusions: These assembled cohorts and described models will provide the framework for an updated FRAX tool enabling enhanced assessment of fracture risk (PROSPERO (CRD42021227266)).

Epidemiology, FRAX, Fracture probability, Hip fracture, Major osteoporotic fracture, Risk assessment
0937-941X
2103-2136
Vandenput, Lisbeth
51275083-bd2d-4d28-9b3b-f07c4d55aeb8
Johansson, H.
05aa5476-bcb9-4b97-905e-00f1dfd9d691
McCloskey, E. V.
e968a69f-27b8-4568-987d-5d8dbbdff3fd
Liu, E.
63b60e12-5d42-4f66-ba55-24da69557b35
Akesson, Kristina E.
467438a5-e6ef-4046-8c1b-8fc102a50579
Anderson, F.A.
e56dcd6d-ea04-46cc-b28f-79048c74eb67
Azagra, R.
e2cf4127-5c23-4b03-933b-352532be22c0
Bager, C.L.
230edb26-7fdf-40c0-9e84-9ed89369cedd
Beaudart, Charlotte
bdc9da98-791a-474b-9745-be0695a4d8a9
Bischoff-Ferrari, H.A.
4540486a-8ebe-40e7-97d3-f3dafcde84ff
Biver, E.
652d49a5-9785-481e-a762-239e284271e1
Bruyère, Olivier
ba727e54-ca17-4fa8-be3d-4729fb4b8c0d
Cauley, J.A.
e34f09a1-b1ed-4c27-af06-380db358aa3c
Center, J.R.
98770407-cc43-44b0-9bbe-4279b86e3167
Chapulat, R.
0ae579ed-7a8d-41ec-a29c-e79fd34e0b83
Christiansen, C.
b1993f77-2024-4daf-b5d8-1ce837315564
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Crandall, Carolyn J.
e768154e-60be-4e70-8398-d080f87d0fff
Cummings, Steven
a32463e0-3493-41db-b46a-543acf9b0f4a
da Silva, J.A.P.
1594f72e-1ea5-4a3e-8245-c1b2c1bde1a6
Dawson-Hughes, Bess
a9df73df-dff4-4a37-b358-abff8d5d2c2d
Diez-Pérez, A.
19f89c53-003a-469c-92ac-69b0b979f3ec
Dufour, Alyssa B.
6c06545e-e17a-4ccd-b153-c955f2a5199e
Eisman, J.A.
58daa855-fccb-4956-b0b6-b47be5c05ecc
Elders, Petra J.M.
548c34f0-0f2b-45e3-a117-9a3f84538fd9
Ferrari, S.
aa19a7ab-b6a7-4abb-a38c-7e972084fa42
Fujita, Y.
b81ab84a-73c3-4cc1-a3ac-5f593bf199f9
Fujiwara, S.
6b72bf43-a69d-4a09-93ee-cba668fa8c57
Glüer, C.C.
26bce742-ab40-46b5-83cd-58940f016e64
Goldstein, I.
9440f665-fa92-44ac-be60-4fc69793fb6f
Goltzman, D.
802008bc-1944-40b8-8324-a955e96526c6
Gudnason, V.
174d32af-83c9-4b84-a29b-7855843e2a21
Hall, J.
d4872b9c-4ab2-4d97-8c72-e6fccce23688
Hans, D.
15c3aea6-ff21-4e0a-ae9d-ef35f5944e79
Hoff, M.
c0818546-2d50-4686-a4c2-dc4a469ba810
Hollick, Rosemary J.
0be6ad0a-16c1-4529-9ced-12ed89996e4f
Huisman, Martijn
185f06fe-e5b0-4744-bd1f-abbb00c10663
Iki, M.
a06c35be-9599-4bb7-a04f-10dffdbe4232
Ish-Shalom, S.
df4c7e5b-f6d0-48cf-af55-cf42adf4c249
Jones, G.
6f771ff0-5f71-4709-be07-8bcf83871a7c
Karlsson, M.K.
28115dd6-7278-4e26-a577-80a9d2c5a3bb
Khosla, Sundeep
741cc170-f434-4b90-9ab5-51a3b6bd1b9f
Kiel, D.P.
436237c2-7806-4572-a92b-acb031fe5504
Koh, W-P
56a5cd01-1d27-4e53-b8de-e4cd94704fe3
Koromani, F.
f10373b1-8123-4d25-b6f3-72774419fea4
Kotowicz, M.A.
ec960308-1484-4089-a8fe-17cf99d762f0
Kroger, H.
cf82e445-f432-421b-90f3-4f78d383ec52
Kwok, T.
01b9b35f-9d20-4af8-8298-0b5af0d197f3
Lamy, Olivier
39062e15-cdda-41a2-bf58-ca696c122291
Langhammer, Arnulf
5237056a-6ae4-4bbc-b7ad-4a40782989c0
Larijani, Bagher
019ae6fa-ffe0-446f-b35c-dde583bc352a
Lippuner, Kurt
5992b024-14b4-4d52-85bd-65484a8ba5bd
Mellström, D
25d526ce-07a0-417c-882d-be2a40a47e35
Merlijn, Thomas
124d8e2b-a77f-4882-927c-fe20b90d69c4
Nordstrom, A.
5909a64e-facf-494e-8b31-bbdaa35fbf02
Nordstrom, P.
2d2a78ba-51d6-471a-a854-e35545cc83c8
O'Neill, T.W.
688d84bf-f76f-4777-a3e1-65c6e5526365
Obermayer-Piestch, B.
9377fe38-55f6-4704-8019-317ede54d2bc
Harvey, Nicholas
ce487fb4-d360-4aac-9d17-9466d6cba145
Kanis, J A.
55c6bd2c-d653-48de-b4b9-29fe280fb00f
Ohlsson, C.
6d508551-6ce9-4849-812d-a8fac1db8bfe
Orwoll, E.S.
f14fefa7-4388-4667-9f8d-dba1fddc45d5
Pasco, J.A.
3643f8c7-37a5-414b-9f54-7a2db8589854
Rivadeneira, F.
818db7d0-e223-4214-a7b8-6c46d98252f3
Schei, B.
98cc7cbf-e64a-4143-85de-e2315c4b85b6
Schott, A.M.
cd19d83a-0556-4b90-b127-f8a8e9712e2a
Shiroma, E.J.
4e35184d-1c5a-450b-a0dc-3906ae4dd589
Siggeirsdottir, K.
97973e08-b38d-4446-97f8-5312e8e5fb5c
Simonsick, E.M.
bbbdebd7-514a-494c-ba74-f5217e0fb444
Sornay-Rendu, E.
ec0be57d-7892-4c0a-8c81-97583b9dcad3
Sund, R.
32187808-54ca-4b95-808a-0b6352952b1d
Swart, K.M.A.
249a32fb-b4ee-4b2a-882e-7e8fe116d058
Szulc, P.
a5d63e26-428e-4894-a070-6cc87b2dd3a2
Tamaki, J.
5da9a209-1294-4d73-86fe-704f1d7fa28e
Torgerson, D.J.
e6809d5d-07fd-412a-8311-3b5e9b67639f
Van Schoor, N.M.
54108e9a-d965-45e0-86a2-a5eccb7f2890
van Staa, T.P.
31b8bfb4-4e1b-4a48-a5a6-90ca601b94af
Vilas, J.C.
fab1dd40-eafd-4db2-87de-064f1f262086
Wareham, N.J
e74c35be-c1c1-4e12-91cf-13a227f5d1fd
Wright, N.C.
3f999ec0-1351-4362-b835-4d76dbde6a9a
Yoshimura, N.
e695935c-7fa8-4b22-bd0e-387446ec615c
Zillikens, M.C.
ec395178-dfe8-46cf-b345-5b26243970d8
Zwart, M.
f762041f-1f0a-44e5-bfd9-f85fa7be17af
Lorentzon, M.
e8945a23-d85b-45e9-bd5a-328162ed548e
Leslie, W.D.
18080f49-4f83-4ec4-a4e4-6b0525df6cc4
Vandenput, Lisbeth
51275083-bd2d-4d28-9b3b-f07c4d55aeb8
Johansson, H.
05aa5476-bcb9-4b97-905e-00f1dfd9d691
McCloskey, E. V.
e968a69f-27b8-4568-987d-5d8dbbdff3fd
Liu, E.
63b60e12-5d42-4f66-ba55-24da69557b35
Akesson, Kristina E.
467438a5-e6ef-4046-8c1b-8fc102a50579
Anderson, F.A.
e56dcd6d-ea04-46cc-b28f-79048c74eb67
Azagra, R.
e2cf4127-5c23-4b03-933b-352532be22c0
Bager, C.L.
230edb26-7fdf-40c0-9e84-9ed89369cedd
Beaudart, Charlotte
bdc9da98-791a-474b-9745-be0695a4d8a9
Bischoff-Ferrari, H.A.
4540486a-8ebe-40e7-97d3-f3dafcde84ff
Biver, E.
652d49a5-9785-481e-a762-239e284271e1
Bruyère, Olivier
ba727e54-ca17-4fa8-be3d-4729fb4b8c0d
Cauley, J.A.
e34f09a1-b1ed-4c27-af06-380db358aa3c
Center, J.R.
98770407-cc43-44b0-9bbe-4279b86e3167
Chapulat, R.
0ae579ed-7a8d-41ec-a29c-e79fd34e0b83
Christiansen, C.
b1993f77-2024-4daf-b5d8-1ce837315564
Cooper, Cyrus
e05f5612-b493-4273-9b71-9e0ce32bdad6
Crandall, Carolyn J.
e768154e-60be-4e70-8398-d080f87d0fff
Cummings, Steven
a32463e0-3493-41db-b46a-543acf9b0f4a
da Silva, J.A.P.
1594f72e-1ea5-4a3e-8245-c1b2c1bde1a6
Dawson-Hughes, Bess
a9df73df-dff4-4a37-b358-abff8d5d2c2d
Diez-Pérez, A.
19f89c53-003a-469c-92ac-69b0b979f3ec
Dufour, Alyssa B.
6c06545e-e17a-4ccd-b153-c955f2a5199e
Eisman, J.A.
58daa855-fccb-4956-b0b6-b47be5c05ecc
Elders, Petra J.M.
548c34f0-0f2b-45e3-a117-9a3f84538fd9
Ferrari, S.
aa19a7ab-b6a7-4abb-a38c-7e972084fa42
Fujita, Y.
b81ab84a-73c3-4cc1-a3ac-5f593bf199f9
Fujiwara, S.
6b72bf43-a69d-4a09-93ee-cba668fa8c57
Glüer, C.C.
26bce742-ab40-46b5-83cd-58940f016e64
Goldstein, I.
9440f665-fa92-44ac-be60-4fc69793fb6f
Goltzman, D.
802008bc-1944-40b8-8324-a955e96526c6
Gudnason, V.
174d32af-83c9-4b84-a29b-7855843e2a21
Hall, J.
d4872b9c-4ab2-4d97-8c72-e6fccce23688
Hans, D.
15c3aea6-ff21-4e0a-ae9d-ef35f5944e79
Hoff, M.
c0818546-2d50-4686-a4c2-dc4a469ba810
Hollick, Rosemary J.
0be6ad0a-16c1-4529-9ced-12ed89996e4f
Huisman, Martijn
185f06fe-e5b0-4744-bd1f-abbb00c10663
Iki, M.
a06c35be-9599-4bb7-a04f-10dffdbe4232
Ish-Shalom, S.
df4c7e5b-f6d0-48cf-af55-cf42adf4c249
Jones, G.
6f771ff0-5f71-4709-be07-8bcf83871a7c
Karlsson, M.K.
28115dd6-7278-4e26-a577-80a9d2c5a3bb
Khosla, Sundeep
741cc170-f434-4b90-9ab5-51a3b6bd1b9f
Kiel, D.P.
436237c2-7806-4572-a92b-acb031fe5504
Koh, W-P
56a5cd01-1d27-4e53-b8de-e4cd94704fe3
Koromani, F.
f10373b1-8123-4d25-b6f3-72774419fea4
Kotowicz, M.A.
ec960308-1484-4089-a8fe-17cf99d762f0
Kroger, H.
cf82e445-f432-421b-90f3-4f78d383ec52
Kwok, T.
01b9b35f-9d20-4af8-8298-0b5af0d197f3
Lamy, Olivier
39062e15-cdda-41a2-bf58-ca696c122291
Langhammer, Arnulf
5237056a-6ae4-4bbc-b7ad-4a40782989c0
Larijani, Bagher
019ae6fa-ffe0-446f-b35c-dde583bc352a
Lippuner, Kurt
5992b024-14b4-4d52-85bd-65484a8ba5bd
Mellström, D
25d526ce-07a0-417c-882d-be2a40a47e35
Merlijn, Thomas
124d8e2b-a77f-4882-927c-fe20b90d69c4
Nordstrom, A.
5909a64e-facf-494e-8b31-bbdaa35fbf02
Nordstrom, P.
2d2a78ba-51d6-471a-a854-e35545cc83c8
O'Neill, T.W.
688d84bf-f76f-4777-a3e1-65c6e5526365
Obermayer-Piestch, B.
9377fe38-55f6-4704-8019-317ede54d2bc
Harvey, Nicholas
ce487fb4-d360-4aac-9d17-9466d6cba145
Kanis, J A.
55c6bd2c-d653-48de-b4b9-29fe280fb00f
Ohlsson, C.
6d508551-6ce9-4849-812d-a8fac1db8bfe
Orwoll, E.S.
f14fefa7-4388-4667-9f8d-dba1fddc45d5
Pasco, J.A.
3643f8c7-37a5-414b-9f54-7a2db8589854
Rivadeneira, F.
818db7d0-e223-4214-a7b8-6c46d98252f3
Schei, B.
98cc7cbf-e64a-4143-85de-e2315c4b85b6
Schott, A.M.
cd19d83a-0556-4b90-b127-f8a8e9712e2a
Shiroma, E.J.
4e35184d-1c5a-450b-a0dc-3906ae4dd589
Siggeirsdottir, K.
97973e08-b38d-4446-97f8-5312e8e5fb5c
Simonsick, E.M.
bbbdebd7-514a-494c-ba74-f5217e0fb444
Sornay-Rendu, E.
ec0be57d-7892-4c0a-8c81-97583b9dcad3
Sund, R.
32187808-54ca-4b95-808a-0b6352952b1d
Swart, K.M.A.
249a32fb-b4ee-4b2a-882e-7e8fe116d058
Szulc, P.
a5d63e26-428e-4894-a070-6cc87b2dd3a2
Tamaki, J.
5da9a209-1294-4d73-86fe-704f1d7fa28e
Torgerson, D.J.
e6809d5d-07fd-412a-8311-3b5e9b67639f
Van Schoor, N.M.
54108e9a-d965-45e0-86a2-a5eccb7f2890
van Staa, T.P.
31b8bfb4-4e1b-4a48-a5a6-90ca601b94af
Vilas, J.C.
fab1dd40-eafd-4db2-87de-064f1f262086
Wareham, N.J
e74c35be-c1c1-4e12-91cf-13a227f5d1fd
Wright, N.C.
3f999ec0-1351-4362-b835-4d76dbde6a9a
Yoshimura, N.
e695935c-7fa8-4b22-bd0e-387446ec615c
Zillikens, M.C.
ec395178-dfe8-46cf-b345-5b26243970d8
Zwart, M.
f762041f-1f0a-44e5-bfd9-f85fa7be17af
Lorentzon, M.
e8945a23-d85b-45e9-bd5a-328162ed548e
Leslie, W.D.
18080f49-4f83-4ec4-a4e4-6b0525df6cc4

Vandenput, Lisbeth, Johansson, H., McCloskey, E. V., Liu, E., Akesson, Kristina E., Anderson, F.A., Azagra, R., Bager, C.L., Beaudart, Charlotte, Bischoff-Ferrari, H.A., Biver, E., Bruyère, Olivier, Cauley, J.A., Center, J.R., Chapulat, R., Christiansen, C., Cooper, Cyrus, Crandall, Carolyn J., Cummings, Steven, da Silva, J.A.P., Dawson-Hughes, Bess, Diez-Pérez, A., Dufour, Alyssa B., Eisman, J.A., Elders, Petra J.M., Ferrari, S., Fujita, Y., Fujiwara, S., Glüer, C.C., Goldstein, I., Goltzman, D., Gudnason, V., Hall, J., Hans, D., Hoff, M., Hollick, Rosemary J., Huisman, Martijn, Iki, M., Ish-Shalom, S., Jones, G., Karlsson, M.K., Khosla, Sundeep, Kiel, D.P., Koh, W-P, Koromani, F., Kotowicz, M.A., Kroger, H., Kwok, T., Lamy, Olivier, Langhammer, Arnulf, Larijani, Bagher, Lippuner, Kurt, Mellström, D, Merlijn, Thomas, Nordstrom, A., Nordstrom, P., O'Neill, T.W., Obermayer-Piestch, B., Harvey, Nicholas, Kanis, J A., Ohlsson, C., Orwoll, E.S., Pasco, J.A., Rivadeneira, F., Schei, B., Schott, A.M., Shiroma, E.J., Siggeirsdottir, K., Simonsick, E.M., Sornay-Rendu, E., Sund, R., Swart, K.M.A., Szulc, P., Tamaki, J., Torgerson, D.J., Van Schoor, N.M., van Staa, T.P., Vilas, J.C., Wareham, N.J, Wright, N.C., Yoshimura, N., Zillikens, M.C., Zwart, M., Lorentzon, M. and Leslie, W.D. (2022) Update of the fracture risk prediction tool FRAX: A systematic review of potential cohorts and analysis plan. Osteoporosis International, 33 (10), 2103-2136. (doi:10.1007/s00198-022-06435-6).

Record type: Review

Abstract

Summary: We describe the collection of cohorts together with the analysis plan for an update of the fracture risk prediction tool FRAX with respect to current and novel risk factors. The resource comprises 2,138,428 participants with a follow-up of approximately 20 million person-years and 116,117 documented incident major osteoporotic fractures. Introduction: The availability of the fracture risk assessment tool FRAX® has substantially enhanced the targeting of treatment to those at high risk of fracture with FRAX now incorporated into more than 100 clinical osteoporosis guidelines worldwide. The aim of this study is to determine whether the current algorithms can be further optimised with respect to current and novel risk factors. Methods: A computerised literature search was performed in PubMed from inception until May 17, 2019, to identify eligible cohorts for updating the FRAX coefficients. Additionally, we searched the abstracts of conference proceedings of the American Society for Bone and Mineral Research, European Calcified Tissue Society and World Congress of Osteoporosis. Prospective cohort studies with data on baseline clinical risk factors and incident fractures were eligible. Results: Of the 836 records retrieved, 53 were selected for full-text assessment after screening on title and abstract. Twelve cohorts were deemed eligible and of these, 4 novel cohorts were identified. These cohorts, together with 60 previously identified cohorts, will provide the resource for constructing an updated version of FRAX comprising 2,138,428 participants with a follow-up of approximately 20 million person-years and 116,117 documented incident major osteoporotic fractures. For each known and candidate risk factor, multivariate hazard functions for hip fracture, major osteoporotic fracture and death will be tested using extended Poisson regression. Sex- and/or ethnicity-specific differences in the weights of the risk factors will be investigated. After meta-analyses of the cohort-specific beta coefficients for each risk factor, models comprising 10-year probability of hip and major osteoporotic fracture, with or without femoral neck bone mineral density, will be computed. Conclusions: These assembled cohorts and described models will provide the framework for an updated FRAX tool enabling enhanced assessment of fracture risk (PROSPERO (CRD42021227266)).

Text
Revision_Vandenput OSIN (003) - Accepted Manuscript
Download (517kB)

More information

Accepted/In Press date: 18 May 2022
e-pub ahead of print date: 31 May 2022
Published date: 31 May 2022
Additional Information: Funding Information: JA Kanis led the team that developed FRAX as director of the WHO Collaborating Centre for Metabolic Bone Diseases; he has no financial interest in FRAX. EV McCloskey, WD Leslie, M Lorentzon, NC Harvey, E Liu, L Vandenput and H Johansson are members of the FRAX team. JA Kanis, NC Harvey and EV McCloskey are members of the advisory body to the National Osteoporosis Guideline Group. JA Kanis reports no additional competing interests. KE Åkesson has no financial interest related to FRAX; chaired the National SALAR Group for Person-Centered Care Pathway Osteoporosis. FA Anderson led the team that developed GLOW, while director of the Center for Outcomes Research at the University of Massachusetts Medical School; he has no financial interest in FRAX. R Azagra has received funding for research from Instituto Carlos III of Spanish Ministry of Health, IDIAP Jordi Gol of Catalan Government and from Scientific Societies SEMFYC and SEIOMM. CL Bager is employed at Nordic Bioscience and owns stock in Nordic Bioscience. She declares no competing interests in relation to this work. HA Bischoff-Ferrari has no financial interest in FRAX. For the DO-HEALTH trial cohort, Prof. Bischoff-Ferrari reports independent and investigator-initiated grants from European Commission Framework 7 Research Program, from the University of Zurich, from NESTEC, from Pfizer Consumer Healthcare, from Streuli Pharma, plus non-financial support from DNP. For the study cohort extension, she reports independent and investigator-initiated grants from Pfizer and from Vifor. Furthermore, Prof. Bischoff-Ferrari reports non-financial support from Roche Diagnostics and personal fees from Wild, Sandoz, Pfizer, Vifor, Mylan, Roche, Meda Pharma, outside the submitted work with regard to speaker fees and travel fees. JR Center has received honoraria for speaking at educational meetings and for advisory boards from Amgen and honoraria for an advisory board from Bayer. R Chapurlat has no financial interest in FRAX. He has received grant funding from Amgen, UCB, Chugai, MSD, Mylan and Medac. He has received honoraria from Amgen, UCB, Chugai, Galapagos, Biocon, Abbvie, Haoma Medica, Pfizer, Amolyt, MSD, Lilly, BMS, Novartis, Arrow, PKMed, Kyowa-Kirin and Sanofi. C Christiansen owns stock in Nordic Bioscience. He declares no competing interests in relation to this work. C Cooper reports personal fees from Alliance for Better Bone Health, Amgen, Eli Lilly, GSK, Medtronic, Merck, Novartis, Pfizer, Roche, Servier, Takeda and UCB. A Diez-Perez reports personal fees from Amgen, Lilly, Theramex and grants from Instituto Carlos III and owns shares of Active Life Scientific, all outside the submitted work. JA Eisman declares consulting and research support from Actavis, Amgen, Aspen, Lilly, Merck Sharp and Dohme, Novartis, Sanofi-Aventis, Servier and Theramex. PJM Elders has no financial interest in FRAX. PJM Elders reports support for the SOS study by Stichting Achmea Gezondheidszorg, Achmea and VGZ zorgverzekeraar. Additional support was given by the stichting Artsenlaboratorium en Trombosedienst. Outside the submitted work, she did receive independent investigator driven grants by Zonmw, the Netherlands, de Hartstichting, the Netherlands, the European foundation for the study of Diabetes, Amgen the Netherlands, TEVA, the Netherlands and Takeda, the Netherlands. NC Harvey has received consultancy/lecture fees/honoraria/grant funding from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Radius Health, Servier, Shire, UCB, Consilient Healthcare and Internis Pharma. DP Kiel has no financial interest in FRAX but has received support for his work in the Framingham Study over the past 30 years by the National Institutes of Health, Astra Zeneca, Merck, Amgen and Radius Health. MA Kotowicz has received funding from the National Health and Medical Research Council (NHMRC) Australia, and the Medical Research Future Fund (MRFF) Australia. He has served on advisory boards for Amgen Australia, Novartic and Eli Lilly — all unrelated to this work and is the Director of the Geelong Bone Densitometry Service. M Lorentzon has received lecture fees from Amgen, Lilly, Meda, Renapharma and UCB Pharma and consulting fees from Amgen, Radius Health, UCB Pharma, Renapharma and Consilient Health, all outside the presented work. EV McCloskey has received consultancy/lecture fees/grant funding/honoraria from AgNovos, Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, Gilead, GSK, Hologic, Internis, Lilly, Merck, Novartis, Pfizer, Radius Health, Redx Oncology, Roche, Sanofi Aventis, UCB, ViiV, Warner Chilcott and I3 Innovus. C Ohlsson is listed as a coinventor on two patent applications regarding probiotics in osteoporosis treatment. ES Orwoll reports consulting fees from Amgen, Biocon, Radius and Bayer, and research support from Mereo. JA Pasco has received funding from the National Health and Medical Research Council (NHMRC) Australia, and the Medical Research Future Fund (MRFF) Australia, all unrelated to this work. MC Zillikens has received honoraria in the past for lectures or advice from Alexion, Amgen, Eli Lilly, Kyowa Kirin, Shire and UCB, unrelated to the current work. M Zwart has received research funding from national societies (SEMFYC and SEIOMM). C Beaudart, E Biver, O Bruyère, JA Cauley, CJ Crandall, SR Cummings, JAP da Silva, B Dawson-Huges, AB Dufour, S Ferrari, Y Fujita, S Fujiwara, C–C Glüer, I Goldshtein, D Goltzman, V Gudnason, J Hall, D Hans, M Hoff, RJ Hollick, M Huisman, M Iki, S Ish-Shalom, H Johansson, G Jones, MK Karlsson, S Khosla, W–P Koh, F Koromani, H Kröger, T Kwok, O Lamy, A Langhammer, B Larijani, WD Leslie, K Lippuner, E Liu, D Mellström, T Merlijn, A Nordström, P Nordström, TW O´Neill, B Obermayer-Pietsch, F Rivadeneira, B Schei, A-M Schott, EJ Shiroma, K Sigeirsdottir, EM Simonsick, E Sornay-Rendu, R Sund, KMA Swart, P Szulc, J Tamaki, DJ Torgerson, L Vandenput, NM van Schoor, TP van Staa, J Vila, NJ Wareham, NC Wright and N Yoshimura declare no competing interests in relation to this work. Funding Information: We thank the Gothenburg University Library for assistance with the systematic review. We are grateful to Dr Östen Ljunggren for contributing the MrOS Sweden cohort. Publisher Copyright: © 2022, International Osteoporosis Foundation and National Osteoporosis Foundation.
Keywords: Epidemiology, FRAX, Fracture probability, Hip fracture, Major osteoporotic fracture, Risk assessment

Identifiers

Local EPrints ID: 469615
URI: http://eprints.soton.ac.uk/id/eprint/469615
ISSN: 0937-941X
PURE UUID: 65cdaadf-a7df-412a-a613-3f5c7b41072f
ORCID for Cyrus Cooper: ORCID iD orcid.org/0000-0003-3510-0709
ORCID for Nicholas Harvey: ORCID iD orcid.org/0000-0002-8194-2512

Catalogue record

Date deposited: 21 Sep 2022 16:38
Last modified: 18 Mar 2024 05:04

Export record

Altmetrics

Contributors

Author: Lisbeth Vandenput
Author: H. Johansson
Author: E. V. McCloskey
Author: E. Liu
Author: Kristina E. Akesson
Author: F.A. Anderson
Author: R. Azagra
Author: C.L. Bager
Author: Charlotte Beaudart
Author: H.A. Bischoff-Ferrari
Author: E. Biver
Author: Olivier Bruyère
Author: J.A. Cauley
Author: J.R. Center
Author: R. Chapulat
Author: C. Christiansen
Author: Cyrus Cooper ORCID iD
Author: Carolyn J. Crandall
Author: Steven Cummings
Author: J.A.P. da Silva
Author: Bess Dawson-Hughes
Author: A. Diez-Pérez
Author: Alyssa B. Dufour
Author: J.A. Eisman
Author: Petra J.M. Elders
Author: S. Ferrari
Author: Y. Fujita
Author: S. Fujiwara
Author: C.C. Glüer
Author: I. Goldstein
Author: D. Goltzman
Author: V. Gudnason
Author: J. Hall
Author: D. Hans
Author: M. Hoff
Author: Rosemary J. Hollick
Author: Martijn Huisman
Author: M. Iki
Author: S. Ish-Shalom
Author: G. Jones
Author: M.K. Karlsson
Author: Sundeep Khosla
Author: D.P. Kiel
Author: W-P Koh
Author: F. Koromani
Author: M.A. Kotowicz
Author: H. Kroger
Author: T. Kwok
Author: Olivier Lamy
Author: Arnulf Langhammer
Author: Bagher Larijani
Author: Kurt Lippuner
Author: D Mellström
Author: Thomas Merlijn
Author: A. Nordstrom
Author: P. Nordstrom
Author: T.W. O'Neill
Author: B. Obermayer-Piestch
Author: Nicholas Harvey ORCID iD
Author: J A. Kanis
Author: C. Ohlsson
Author: E.S. Orwoll
Author: J.A. Pasco
Author: F. Rivadeneira
Author: B. Schei
Author: A.M. Schott
Author: E.J. Shiroma
Author: K. Siggeirsdottir
Author: E.M. Simonsick
Author: E. Sornay-Rendu
Author: R. Sund
Author: K.M.A. Swart
Author: P. Szulc
Author: J. Tamaki
Author: D.J. Torgerson
Author: N.M. Van Schoor
Author: T.P. van Staa
Author: J.C. Vilas
Author: N.J Wareham
Author: N.C. Wright
Author: N. Yoshimura
Author: M.C. Zillikens
Author: M. Zwart
Author: M. Lorentzon
Author: W.D. Leslie

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×